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Excess salt intake could affect the immune system by shifting the immune cell balance
toward a pro-inflammatory state. Since this shift of the immune balance is thought
to be beneficial in anti-cancer immunity, we tested the impact of high salt diets
on tumor growth in mice. Here we show that high salt significantly inhibited tumor
growth in two independent murine tumor transplantation models. Although high salt fed
tumor-bearing mice showed alterations in T cell populations, the effect seemed to be
largely independent of adaptive immune cells. In contrast, depletion of myeloid-derived
suppressor cells (MDSCs) significantly reverted the inhibitory effect on tumor growth. In
line with this, high salt conditions almost completely blocked murine MDSC function in
vitro. Importantly, similar effects were observed in human MDSCs isolated from cancer
patients. Thus, high salt conditions seem to inhibit tumor growth by enabling more
pronounced anti-tumor immunity through the functional modulation of MDSCs. Our
findings might have critical relevance for cancer immunotherapy.
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INTRODUCTION
The balance between pro- and anti-inflammatory cells and signals is critical for preserving immune
homeostasis and a disturbed immune cell balance is believed to contribute to autoimmunity and
cancer. Recent data have demonstrated that a high salt diet (HSD) could influence the immune
cell balance toward a pro-inflammatory state, where the induction of pro-inflammatory cells,
such as T helper 17 cells (TH17) and M1-like macrophages is promoted and the function of
anti-inflammatory cells, such as M2-like macrophages and regulatory T cells (Tregs) is impaired
(1–4). High salt intake is a ubiquitous phenomenon of Western diets and is indeed implicated
in a plethora of diseases like cardiovascular and metabolic as well as autoimmune diseases (5, 6).
Particularly the pro-inflammatory effects of a HSD are believed to be associated with autoimmune
diseases like e.g., multiple sclerosis (MS) and inflammatory bowel diseases (IBD) (7). These
pro-inflammatory effects of high salt on the immune cell balance raise the question if high salt
conditions could also affect anti-tumor immunity and cancer.
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The immune system is able to recognize neoplasms and
after therapeutic intervention it can also attack and eradicate
tumors as recent advances in the field of cancer immunotherapy
(e.g., immune checkpoint inhibition) have shown. Indeed,
immunotherapy is one of the most promising approaches to treat
cancer (8, 9). However, a major obstacle for successful cancer
immunotherapy is the highly immuno-suppressive environment
induced by many tumors. It is well-documented that the tumor
microenvironment frequently induces an immune protective
and tolerogenic environment by e.g., promoting the induction
of various immune suppressive cell types or by inducing the
expression of immune suppressive cytokines (10–14).
Important players in the tumor microenvironment
are myeloid cells, which can support tumor growth by
providing growth factors, such as vascular endothelial
growth factor (VEGF) (15) and additionally can be strongly
immunosuppressive. One of these tumor promoting myeloid
cell types are myeloid-derived suppressor cells (MDSCs)
(16–18). MDSCs are a classically defined as a heterogeneous
population of immature myeloid cells that fail to terminally
differentiate and exert a strong immune suppressive potential
in mice and humans. The induction of MDSCs from myeloid
progenitors occurs in the bone marrow (BM) and spleen usually
in the context of chronic inflammation and often leads to
an accumulation of these cells in the periphery in cancerous
conditions. Here they can inhibit various other immune cells
like T and B cells, dendritic cells (DC) and natural killer cells
(NK) and thereby contribute to an immune suppressive state
using different molecular mechanisms of suppression. However,
also in the absence of T cells, GR1 positive myeloid cells can
support tumor growth (19) e.g., by the promotion of tumor
angiogenesis (15). The presence of MDSCs in cancer patients is
associated with a poor disease prognosis and tumor recurrence
(17, 20). MDSCs can be further subdivided based on their origin
and phenotype into granulocytic or polymorphonuclear MDSCs
(PMN-MDSCs) and monocytic (M-MDSCs) (17, 21). Both
MDSC subsets can be frequently detected in BM, spleen, blood
and tumor tissues of cancer patients. In mice PMN-MDSCs are
defined as CD11b+Ly6GhighLy6Clow, whereas M-MDSCs are
defined as CD11b+Ly6G−Ly6Chigh cells, although both marker
combinations are not entirely specific and can also include
neutrophils or classical monocyte populations (17). In humans
PMN-MDSCs are characterized by CD11b+CD14−CD15+HLA-
DR− or CD11b+CD14−CD66b+ expression and M-MDSCs
are CD11b+CD14+CD15−HLA-DRlow/− cells (17). MDSCs
further show a high grade of plasticity. They can react to
environmental triggers like altered cytokine milieus or hypoxia
and adapt their phenotype and function accordingly or can
even differentiate into cells with pro-inflammatory potential
(18, 22). However, how and if MDSCs react to changes in the
ionic microenvironment as e.g., found in tumor tissues through
increased necrosis (23) or through induction by HSD (24, 25)
is unknown.
Since high salt affects various adaptive and innate immune
cells it is plausible that MDSCs may also react to elevated
Na+ concentrations. Considering the immune stimulatory effects
of high salt, these conditions may be favorable for enhanced
tumor immunology by boosting pro-inflammatory effector cells
and blocking anti-inflammatory cells. We therefore sought to
analyze the impact of HSD on tumor growth in murine tumor
transplantation models. Here we show that a HSD significantly
reduces tumor growth in two independent tumor transplantation
models. The effect seems to be largely dependent on myeloid
cells by impacting MDSC function and thereby leading to
enhanced anti-tumor immunity. Thus, our study identified a
novel effect of how high dietary salt intake could modify innate
immune reactions by modulating murine and human MDSC
function. These data may offer novel strategies for improving
cancer immunotherapies.
MATERIALS AND METHODS
Mice
C57BL/6 mice were purchased from Charles River and housed
in the facility of the University of Hasselt under standardized
conditions. Further, C57BL/6 mice were purchased from
Janvier and housed in the facility of Vrije Universiteit Brussel
(VUB) under standardized conditions. RAG2−/− mice were
kindly provided by Thomas Blankenstein. Animal studies were
approved by the ethics committees of animal studies at the
University of Hasselt (201738) and VUB (14-220-26).
Diet and Tumor Inoculation
Mice were either fed a normal diet (Control group) containing
0.5% NaCl or sodium enriched diet (HSD group) containing
4% NaCl as well as 1% NaCl enriched tap water for 2 weeks
before tumor inoculation. In some experiments, diet switch
was started directly before tumor inoculation. Both diets were
purchased from SSNIFF (Ctrl: E15430-04, HSD: E15431-34;
Soest, Germany). Mice were maintained on the respective diet
during the course of the experiment. B16F10 melanoma cells
(ATCC) were cultured in DMEM (Sigma Aldrich) supplemented
with 10% FCS (Gibco) and Penicillin/Streptomycin (Gibco)
and Lewis Lung carcinoma (LLC) cells (ATCC) were
cultured in RPMI (Lonza) supplemented with 10% FCS
and Penicillin/Streptomycin. Cells were maintained mycoplasma
free, tested continuously by HEK-blue mycoplasma detection
(Invivogen). Tumor cells were subcutaneously injected in the left
abdominal flank (LLC at 1 × 10e6 expose 6 and B16F10 at 2 ×
10e5 expose 5 cells/mouse). Tumor growth was monitored three
times per week by using a caliper. Tumor volume was calculated
with the ellipsoid formula (pi/6∗a∗b∗c) as described before (26).
Flow Cytometry and Preparation of Single
Cell Suspensions
Blood was taken by tail vein puncture. Spleens and lymph
node(s) were mashed through a 70µm cell strainer. Tumor
tissue was minced and subjected to digestion cocktail containing
collagenase at 500µg/ml and DNAse at 40 units/ml for 30min
at 37◦C and passed through a 70µm cell strainer. Single cell
suspensions were subjected to red blood cell lysis (eBioscience).
Cells were washed with MACS buffer (0.5% BSA 2mM EDTA)
and subjected to flow cytometry (further named FACS) staining
protocol or resuspended in complete RPMI medium and
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restimulated with 50 ng/ml phorbol 12-myristate 13-acetate
(PMA) and 250 ng/ml Ionomycin (Sigma) in the presence of
GolgiPlug (BD) for 5 h to detect cytokines by FACS. Single cell
suspensions were firstly stained with fixable Live/Dead cell kit
(Thermo Fisher Scientific) for 10min at room temperature. Cells
were then incubated with antibody cocktails for 30min at 4◦C
in MACS buffer. Intracellular staining was performed using the
FoxP3 staining kit (eBioscience) according to the manufacturers
protocol. The following antibodies were used: CD3 (Biolegend or
eBioscience, 17A2), CD4 (Biolegend or BD Pharmingen, RM4-5),
CD8 (eBioscience, 53-6.7), CD11b (eBioscience, M1/70), CD25
(BD Pharmingen, PC61), CD44 (eBioscience, IM7), CD45.2 (BD,
104), CD62L (eBioscience,MEL-14), CD183 (Biolegend, CXCR3-
173), CD192 (Biolegend, SA203G11), CD196 (Biolegend, 29-
2LI7), CD274 (Biolegend, 10F.9G2), CD279 (BD, J43), FoxP3
(eBioscience, FJK-16s), F4/80 (eBioscience, BM8), I-A/I-E (BD,
M5/114.15.2), IFNγ (eBioscience, XMG1.2), IL-9 (Biolegend,
RM9A4), IL-10 (eBioscience, JES5-16E3), IL-17 (eBioscience,
eBio17B7), Ly6C (Biolegend, HK1.4), Ly6G (Biolegend, 1A8),
Siglec-F (BD, E50-2440) and TNFα (Biolegend, MP6-XT22),
Eomes (eBioscience, Dan11mag), T-bet (Biolegend, 4B10),
CD19 (Biolegend, MB19-1), CD5 (Biolegend, 53-7.3). MDSCs
were defined as CD11b+Ly6ChighLy6G− (M-MDSC) and as
CD11b+Ly6CmedLy6Ghigh (PMN-MDSC) pre gated on CD45.2+
live cells excluding doublets and dead cells. Cells were acquired
on a BD FACS-Fortessa instrument (BD) and analyzed using
FlowJo V.10.1 software (FlowJo LLC) and by using FlowSOM.
FlowSOM Analysis
FACS data was manually gated on single live and/or CD11b+
or CD4+ T cells and later exported as FCS files in FlowJo
V.10.1 (FlowJo, LLC). The automated analysis of exported FCS
files was done by using FlowSOM algorithm, a R bioconductor
package that uses self-organizingmaps for dimensional reduction
visualization of flow cytometry data (27). All data was
concatenated scaled and logical transformed on import. Cells
were assigned to a Self-Organizing Map (SOM) with a 10 × 10
grid, grouping similar cells into 100 nodes. Each node in the
FlowSOM tree gets a score indicating its correspondence with
this requested cell profile. To visualize similar nodes in branches,
a minimal spanning tree (MST) was constructed and cell counts
were log scaled and nodes with similar expression markers were
clustered within metaclusters. The FlowSOM algorithm was run
three times to ensure reproducibility of the results. Comparisons
between groups (HSD and Ctrl) were performed using a Mann-
Whitney test by computing the mean percentage per sample
group in each cluster and by testing statistical significance on
every node within metaclusters. P-values were two-sided and
analysis was performed using RStudio (version 3.4.4).
Apoptosis Assay
B16F10 and LLC cells were cultured under 40mM NaCl
concentration or 80mM Mannitol (Sigma Aldrich) as an
osmolyte control and additional control cells were cultured in
medium only. Cells were harvested after 48 h by trypsinization
and resuspended in AnnexinV binding buffer (0.01M Hepes,
0.14M NaCl, 2.5mM CaCl2). AnnexinV-FITC (BD) was added
for 30min. Propidium iodide (PI) was added at 1µg/ml shortly
before acquisition on a FACS Calibur instrument (BD).
ELISA
Serum samples from tumor-bearing control and HSD fed mice
were subjected to TNFα-, IL17A, IL-10-, and IFNγ- specific
ELISA. All ELISA-kits were purchased from RD-Systems and
performed according to the manufacturers protocol. Finally,
wells were incubated with the horseradish peroxidase substrate
o-phenylenediamine dihydrochloride (OPD) (Thermo Scientific)
and optical density measurement was done on the iMark
microplate reader (Biorad) with a 450 nm wavelength filter.
Antibody Depletion
Anti-Gr-1 (clone RB6-8C5) depletion antibody was purchased
from BioXCell (West Lebanon, NH). 200 µg were i.p. injected
4 days after tumor injection and later on every second day.
Control mice received PBS injection at the same time. Depletion
efficiency was monitored by FACS analysis of blood samples
using antibodies against CD11b and Ly6-C.
Quantitative Real-Time PCR
Tumor or spleen tissue was placed in RLT buffer containing
b-mercaptoethanol and shredded in a Tissue-lyser (Qiagen).
RNA was isolated from the lysates using the RNeasy Kit
(Qiagen). RNA was reversely transcribed using the Quanta
cDNA Kit (Quanta Biosciences). Quantitative real-time PCR was
performed with the Power up SYBR Green Master Mix (Applied
Bioscience). Samples were measured on the Step ONE Plus
RT-PCR machine (Applied Biosciences). The following primers
were used: Tnfα forward: 5′-GAGCAATGACTCCAAAGTAG-
3′, Tnfα reverse: 5′-CGTAGCAAACCACCAAGTGG-3′,
Ifnγ forward: 5′-AAAGAGATAATCTGGCTCTGC-
3′, Ifnγ reverse: 5′-GCTCTGAGACAATGAACGCT-3′,
Nos2 forward: 5′-CCCTTCAATGGTTGGTACATGG-
3′, Nos2 reverse: 5′-ACATTGATCTCCGTGACAGCC-3′,
IL-10 forward: 5′-ATAACTGCACCCACTTCCCA-3′, IL-
10 reverse: 5′-GGGCATCACTTCTACCAGGT-3′, Csf2
forward: 5′-TTTACTTTTCCTGGGCATTG-3′, Csf2 reverse:
5′-TAGCTGGCTGTCATGTTCAA-3′, Sgk1 forward:
5′-CCAAACCCTCCGACTTTCAC-3′, Sgk1 reverse: 5′-
CCTTGTGCCTAGCCAGAAGAA-3′, Il17a forward:
5′-ATCCCTCAAAGCTCAGCGTGTC-3′, Il17a reverse:
5′-GGGTCTTCATTGCGGTGGAGAG-3′, Pbgd forward:
5′ TGGTTGTTCACTCCCTGAAGG-3′ and Pbgd reverse:
5′-AAAGACAACAGCATCACAAGGGT-3′, Hprt forward:
5′-GTTGGATACAGGCCAGACTTTGTT-3′ and Hprt reverse:
5′-GAGGGTAGGCTGGCCTATAGGCT-3′. Data was analyzed
by 2−11Ct method.
Murine MDSC Isolation and Suppression
Assay
Subcutaneous LLC tumors were excised and treated with 10
U/ml collagenase I, 400 U/ml collagenase IV and 30 U/m1
DNase I (Worthington) for 30min at 37◦C. Tumors and spleens
were squashed and filtered. Red blood cells in spleen and
tumor cell suspensions were removed using erythrocyte lysis
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buffer. To purify MDSCs, CD11b+ cells were enriched by
using anti-CD11b microbeads (Miltenyi Biotec). MDSCs were
sorted from CD11b+ cells using FACS Aria II (BD Biosciences)
(Supplementary Figure 10). Post sort analysis revealed on
average cell purity above 90%. For suppression assays, sorted
MDSCs were added at different ratios to splenocytes (2 ×
105 splenocytes/well) stimulated with anti-CD3 (1µg/ml) and
anti-CD28 (2µg/ml) in flat-bottom 96-well plates in RPMI
medium supplemented with 10% FCS, 300µg/ml L-glutamine,
100 U/ml penicillin, 100µg/ml streptomycin, 1mM sodium
pyruvate, 1mM non-essential amino acids and 0.02mM 2-
mercaptoethanol in the presence or absence of additional 40mM
NaCl or 80mM Mannitol solution in the cultures. After 24 h,
3H-thymidine was added and T-cell proliferation was measured
after another 18 h of culture as counts per minute (cpm) on a
Wallac 1450 Liquid Scintillation Counter. Suppressive capacity of
MDSCs isolated from HSD or control diet receiving animals was
measured in a similar manner, without adding additional NaCl.
Human MDSC Isolation and Suppression
Assay
PMN-MDSCs and autologous CD3+ responder T cells from
cancer patients were isolated and tested in suppression assays
as described before (28). In brief, MDSCs were isolated from
CD3-depleted PBMC by FACS using anti-human CD66b-FITC,
anti-human CD33PE, anti-human HLA-DR-APC, and anti-
human lineage cocktail (CD3, CD20, CD19, CD56, all BV421).
Post sort analysis by FACS revealed a purity of at least 90%.
T lymphocytes were labeled with 10µM Cell Proliferation
Dye eFluor R© 450 (CPDye405) according to manufacturer
instructions (eBioscience, Frankfurt am Main, Germany). For
induction of T cell proliferation cells were stimulated in L-
arginine free RPMI 1640 medium (Thermo Fisher scientific,
Karlsruhe, Germany) supplemented with 10% (v/v) heat-
inactivated FCS, 100 IU/ml penicillin, 100 mg/ml streptomycin
(Thermo Fisher scientific), and 150µML-Arginine (both Sigma-
Aldrich) in 96 well round bottom plates coated with CD3
(1µg/ml, clone OKT-3, eBioscience) and CD28 (2µg/ml, clone
28.2, Beckman coulter). Autologous PMN-MDSC subsets were
added in a T-cell: MDSC ratio of 2.5:1. To study the effect of
high salt conditions additional 40mM NaCl solution (Sigma-
Aldrich) were added to the medium. CPDye405 intensity was
analyzed by flow cytometry after 4 days of co-culture and
proliferation. Proliferation index calculation is based on dye
dilution and was calculated with ModFit LT3.3 (Verity Software,
Topsham, US) according to an algorithm provided by the
software. Written informed consent was obtained from all
human subjects prior to inclusion in this project in accordance
with the ethical standards of the institutional review board,
ethical approval was granted by University of Essen, Germany
(07/3500 and 16/7135).
Immunohistochemistry
Immunohistochemistry on tumor sections was done as described
before (26). In brief, 5µm sections of OCT-tissue tech (Sakura)
embedded LLC tumor tissues were mounted on slides air-
dried overnight and fixed in acetone for 10min and air-dried
for another 20min. Slides were treated with 0.2% galantine
(Sigma Aldrich) and 0.2% Triton X-100 in PBS and additionally
blocked with antibody diluent (Dako) for 1 h at RT. All antibody
stainings were performed in Dako antibody diluent solution.
Primary antibodies were incubated overnight at 4◦C. After 3
times washing with PBS, second antibodies were added for
1 h together with Hoechst 33342 (Sigma Aldrich) at room
temperature. Negative controls were generated by staining with
secondary antibodies and Hoechst 33342 only. After staining,
the slides were covered with slowfade (Life Technologies) and
analyzed with ObserverD.1 or LSM710 confocal microscopes
(Zeiss). The following anti-mouse antibodies were used for
confocal and fluorescence microscopy: CD31 (clone MEC13.3,
BD # 550274, isotype control rat IgG2a), cleaved caspase 3 (cell
signaling # 9604S), CD146 (clone ME9-F1, BD # 562230, isotype
control rat IgG2a). As secondary antibodies Alexa 488-, Alexa
568-, and Alexa 647- labeled: anti-rat IgG and anti-rabbit IgG
(Life Technologies) were used. Hoechst 33342 was used for
staining nuclei.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
(GraphPad Software). Data were analyzed by unpaired t-test.
Data tested against a specified value were analyzed by one-sample
t-test. Repeated measurement two-way ANOVA using Sidak’s
multiple comparison tests was applied on tumor growth data.
Data were presented, if not indicated elsewhere, as mean ±
S.E.M. P < 0.05 was considered to be statistically significant (∗p
< 0.05, ∗∗p< 0.01, ∗∗∗p< 0.001).
RESULTS
High Salt Intake Inhibits Tumor Growth in
Mice
To examine the effects of HSD on cancer development we
used the B16F10 syngeneic melanoma transplantation model.
This poorly immunogenic tumor model (29, 30) was chosen
to analyze possible immune activating effects of a HSD in
mice. We first applied a protocol previously used in models
of hypertension and autoimmunity by pre-feeding mice with
a 4% NaCl containing chow and 1% NaCl in the drinking
water compared to a control diet before tumor inoculation
(Figure 1A) (1, 4). Of note, HSD fed mice showed a significantly
inhibited tumor growth in the B16 tumor model (Figure 1B).
Delayed tumor outgrowth was evident as early as day 11
post-injection (p.i.), leading to significant differences in tumor
size between both groups at day 13 p.i. and at the day of
sacrifice (day 15–17 p.i.) (Figures 1B,C). This effect seemed
to be specific for the dietary regimens, since besides water
intake no other confounders like e.g., general appearance, weight
gain, and food intake were different (Supplementary Figure 1
and data not shown) nor was there a direct effect of high
sodium concentrations (additional 40mM NaCl) on tumor cell
viability during in vitro culture nor any effect of mannitol
as an osmolyte control (Supplementary Figure 2). The NaCl
concentrations used in vitro are comparable to the in vivo
situation in high salt fed animals (24, 25). Only at concentrations
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FIGURE 1 | High salt diet inhibits tumor growth in mice. (A) Experimental design. C57BL/6 mice were kept on control diet (Ctrl) or were fed a high salt diet (HSD)
before tumor inoculation. After tumor challenge the mice were further kept on the same diets until sacrifice. (B) Mice pre-fed on the respective diets were challenged
with B16F10 melanoma cells by subcutaneous (s.c.) injection. Growth curve and dotplot shows tumor volume as mean ± S.E.M. (n = 11) at the indicated time points
pooled from two of three independent experiments with similar results. (C) Representative pictures were taken from tumors of control and HSD fed mice at day 15
post-induction (p.i.) (scale bar = 1 cm). (D) Mice that were fed a control diet or HSD for 2 weeks were subcutaneously injected with Lewis lung carcinoma cells (LLC)
and tumor growth was monitored over time. Growth curve and dotplots shows tumor volume as mean ± S.E.M. (n = 8) at the indicated time points from one
representative of three independent experiments with at least 5 mice per group. (E) Representative pictures were taken from LLC tumors of control and HSD fed mice
at day 20 p.i. (scale bar = 1 cm). Statistical analysis was performed by Two-way repeated-measure Anova test (**p < 0.01, ***p < 0.001).
much higher than 40mM NaCl high salt conditions were toxic
to tumor cells as reported for other tested cell types before
(1) (Supplementary Figure 2). To examine if the results were
reproducible also in other transplanted tumor models, we tested
the HSD regimen in the Lewis lung carcinoma model (LLC)
(31). Similar to the B16 model, HSD also significantly delayed
LLC tumor growth (Figures 1D,E). Thus, HSD was able to
significantly inhibit tumor growth in two independent tumor
transplantation models.
Salt-Induced Changes of the Immune
System in Tumor-Bearing Mice
Since it is well-known that a HSD could have a profound
impact on the host immune system by several mechanisms (7)
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we first analyzed general immune parameters in tumor-bearing
mice receiving a HSD compared to controls. Transcriptional
analysis by quantitative real-time PCR with reverse transcription
(qRT-PCR) of tumor tissue from mice at day 15–17 after
tumor cell inoculation revealed a significant increase of tumor
necrosis factor alpha (Tnfα), interferon-γ (Ifnγ ) and a tendency
of increased nitric oxide synthase 2 (Nos2) expression (p
= 0.0549), whereas transcripts for interleukin (IL) 10 (Il10)
and granulocyte macrophage-colony stimulating factor 2 (Csf2)
remained unchanged (Figure 2A). The expression of serum
and glucocorticoid-regulated kinase (Sgk1), as a prominent salt
signature gene (32) was similarly not changed (Figure 2A).
When analyzing spleen cells from tumor-bearing mice at day
15–17 p.i., we detected similarly significant changes in Tnfα,
Ifnγ , and Nos2 expression and a significant increase in Sgk1
expression (Figure 2B). Similar to the LLC model, we found
increases in Tnfα, Ifnγ , and Nos2 expression in the HSD B16
model (Supplementary Figure 3A). However, in both tissues we
were unable to detect changes in Il17a expression. Moreover,
ELISA-mediated analysis of serum cytokines of tumor-bearing
animals on day 15–17 p.i. did not show any differences for
TNFα, IFNγ, IL-10, or IL-17A between both groups (data not
shown). However, by intracellular FACS analysis we detected
increases of TNFα and IFNγ expression in tumor infiltrating cells
(Supplementary Figure 3B).
We next analyzed by FACS the abundance of CD3+, CD4+,
and CD8+ T cells in different tissues of tumor-bearing mice.
FACS analysis of tumors, spleens, peripheral blood, tumor
draining lymph nodes (dLN) and mesenteric lymph nodes
(mLN) revealed no significant changes between control and
HSD groups (Figure 2C; Supplementary Figure 3C). Although
there were no obvious changes in T cell populations, particularly
the higher expression of Tnfα and Ifnγ indicated a more
pro-inflammatory environment in HSD fed mice compared
to controls and suggests that the observed effect of delayed
tumor growth is potentially related to changes in the host
immune system.
High Salt Mediated Effect on Tumor
Growth Is Largely Independent of T Cells
Since it is known that a HSD can profoundly affect the phenotype
and function of CD4+ T cells, particularly TH17 cells and
Tregs (1, 4, 6, 33, 34), we further examined these subsets
in more detail in tumor-bearing animals receiving either a
HSD or control diet by multicolor FACS analysis of different
tissues as shown in Figure 2C. In line with the increased
cytokine expression (Figures 2A,B; Supplementary Figure 3A),
we detected a significantly higher number of effector-memory
CD4+ T cells (TEM) and TH1-like cells in the mLN of HSD fed
tumor-bearing mice based on an antibody panel containing CD3,
CD4, CD44, CD62L, CCR6, and CXCR3 specific antibodies by
FlowSOM analysis at day 15–17 p.i. (Figure 3A). However, cells
isolated from other tissues, including tumor-infiltrating cells, did
not show any significant differences (Supplementary Figure 4
and data not shown). The higher percentage of TEM cells was
confirmed by a manual gating strategy for CD44 and CD62L
expression in CD4+ T cells of mLN (Figure 3B). HSD fed
animals further displayed a higher percentage of CXCR3+ CD4+
T cells in mLN cells, indicative of an increase in TH1 cells in HSD
fed tumor-bearing animals (Figure 3C). Of note, an increase of
TH1 cells was reported before in a model of lupus nephritis in
an SGK1 dependent manner (35) and possibly could explain
the HSD mediated effect on tumor growth. However, we only
detected subtle changes of Sgk1 expression (Figures 2A,B) that
makes this scenario unlikely. Moreover, there seemed to be no
changes in TH17-like cells based on CCR6 chemokine receptor
expression (Figure 3C).
We next extended the analysis by intracellular FACS after
PMA/ionomycin restimulation in vitro for intracellular cytokine
detection. Again, we were not able to detect significant changes
for IL-17A (Figure 3D), indicating that TH17 cells may not play a
significant role in the delayed tumor growth of animals receiving
a HSD. In contrast to the observed increases of TH1-like cells,
we were also not able to detect more IFNγ expressing cells in
HSD fed mice, indicating that the observed increase of TH1-like
cells based on CXCR3 expression in mLN is of rather minor
relevance (Figure 3D). This was similar in all tissues analyzed
(data not shown).
Since we and others demonstrated before that a HSD could
also impact Foxp3+ Tregs (7, 34), for instance by inducing a TH1-
like effector phenotype, we carefully analyzed the frequency and
cytokine expression of Tregs in different tissues of both groups.
However, the detailed analysis of Foxp3+ Tregs did not show
any significantly altered frequency or phenotype (Figures 3E,F;
Supplementary Figure 5) indicating that Tregs may not play a
critical role in the HSD induced delayed tumor growth in this
model. Besides CD4+ T cells, we were not able to detect any
significant changes in CD8+ T cells nor NK cells in the tissues
and at time points analyzed (Supplementary Figures 6, 7).
Having analyzed changes in the phenotype and function of
T cells in high salt fed tumor-bearing mice, we next wanted to
directly evaluate the contribution of T cells to tumor growth
reduction mediated by HSD. To this end, we applied a similar
tumor transplantation model using LLC and B16 tumor cells
in RAG2 deficient animals, completely lacking mature T and
B cells (36). Surprisingly, while tumor growth reduction was
slightly less efficient, the HSD effect was still detectable in RAG2
deficient mice (Figure 3G; Supplementary Figure 8), indicating
that T cells rather play a minor role in this model. Thus,
although we were able to detect differences in T cell populations
between both groups, the HSD mediated effect on tumor growth
seemed to be mostly independent of alterations in T cells as well
as B cells.
High Salt Intake Modulates
Myeloid-Derived Suppressor Cells
Since T cells were not the major driving force behind the HSD
mediated effect on tumor growth, we further analyzed innate
immune cells in more detail. We and others have shown before
that particularly M1-type- and M2-type macrophages were
sensitive to HSD conditions (2, 3, 37). Thus, we hypothesized
that innate immune cells may be key for the observed effect
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FIGURE 2 | High salt diet creates a pro-inflammatory environment in tumor-bearing mice. (A) Quantitative RT-PCR analysis of LLC tumor tissue. Bar graphs show fold
change as mean ± S.E.M. from HSD samples normalized to control samples. Data are pooled from two independent experiments (n = 8–10). (B) Quantitative
RT-PCR analysis of spleen samples from LLC tumor-bearing mice. Bar graphs show fold change as mean ± S.E.M. from HSD samples normalized to control samples
(n = 5). (C) Tumors as well as the indicated organs from tumor-bearing mice were subjected to FACS analysis of T cell subsets. Cellular events were defined
according to an extended lymphocyte gate, excluding doublets and dead cells. T cells were defined as CD3+ and further gated according to CD4 and CD8
expression. Bar graphs show mean ± S.E.M. of CD3+ cells (upper row), CD4+ T cells (center row, gated on CD3+), and CD8+ T cells (lower row, gated on CD3+).
Samples were analyzed on day 15–17 p.i. statistical significance was determined by t-test (*p < 0.05, **p < 0.01).
of inhibited tumor growth in HSD receiving animals. In this
respect, particularly myeloid-derived suppressor cells are known
to have a critical impact on tumor growth (17, 28). MDSCs
are classified as myeloid cells with suppressive function and
can be identified in mice using the markers CD11b, Ly6C,
and Ly6G for PMN-MDSC (CD11b+Ly6GhighLy6Clow) and M-
MDSCs (CD11b+Ly6G−Ly6Chigh) (17, 28, 38–40).
We examined subsets of myeloid cells including potential
MDSC populations in tumor-bearing mice receiving either HSD
or control diet by FACS in different tissues at different time
points (Figure 4). Of note, FlowSOM analysis of samples from
peripheral blood at day 14 p.i. showed significant changes in
myeloid cell populations (Figure 4A). We observed a similar
trend in CD11b+Ly6GhighLy6Clow PMN-MDSCs by manual
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FIGURE 3 | The impact of T cells on high salt mediated reduced tumor growth. (A) FlowSOM visualization of flow cytometry data across mesenteric lymph nodes
(mLN). Single live CD4+ cells for each sample (Ctrl, n = 4; HSD, n = 4) were exported and concatenated then analyzed using FlowSOM, which arranges the cells into
(Continued)
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FIGURE 3 | clusters (represented by circles) according to similarities in their expression profiles. Each node represents one cluster (total = 100 nodes). Colored nodes
highlight statistically significant changes (p < 0.05) in cell population between two groups (HSD and Ctrl). (B) The same mLN samples as in (A) were analyzed by
manual gating for (B) CD4+ effector-memory T cells (CD44+CD62L−). (C) Th1-like cells (CD4+CXCR3+) and Th17-like cells (CD4+CCR6+). (D) IL-17 and IFNγ
producing CD4+ T cells after PMA/Ionomycin restimulation and intracellular staining. Statistical significance was determined by unpaired t-test (*p < 0.05).
(E) FoxP3+CD25+ regulatory T cells in tumor-bearing mice. FACS plots show the indicated parameters after pre-gating on CD3+CD4+ T cells. Dotplots show
frequency of the indicated populations as mean ± S.E.M. (n = 4/group) representative of three independent experiments. (F) IFNγ-producing regulatory T cells after
restimulation of mLN single cell suspensions from LLC tumor-bearing mice. Representative FACS plots show FoxP3 against IFNγ after pre-gating on CD3+CD4+ T
cells. Dotplots show frequency of FoxP3+ IFNγ+ cells as mean ± S.E.M. from 4 to 5 mice in each group. Similar results were obtained from B16 tumor-bearing mice.
(G) RAG2−/− mice were fed a high salt diet (HSD) or control diet (Ctrl) and challenged with LLC tumor cells. Growth curve shows tumor volume as mean ± S.E.M. for
7 mice in each group. Statistical analysis was performed by Two-way repeated-measure Anova test (*p < 0.05, **p < 0.01).
gating (Figure 4B; Supplementary Figure 9) and confirmed an
increase of PMN-MDSCs at day 14 p.i. (p = 0.0559) as
well as day 9 (p = 0.1336), although not reaching statistical
significance. When analyzing MDSC subsets in tumors and
spleens at day 15–17 p.i., however, we could not detect any
significant differences in frequencies of MDSCs (Figure 4C;
Supplementary Figure 10). In addition, we could not reveal
any significant changes in monocyte/macrophage populations
(Figure 4C; Supplementary Figure 10), indicating that by HSD
the composition of myeloid cell populations was changed
systemically (in peripheral blood) but not locally in the tumor.
Since MDSCs could also affect tumor angiogenesis (15), we
analyzed abundance of endothelial cells in tumor sections by
CD31 immunohistology. Specificity for blood vessel endothelial
cells was confirmed by CD146 co-staining (41) (data not
shown). However, we could not detect major differences in
CD31 staining indicative for alterations in the degree of tumor
angiogenesis between the two groups at time points analyzed
(Supplementary Figure 11).
The above data suggested that HSD induced changes on
the myeloid compartment and that particularly MDSCs might
be key to HSD induced inhibited tumor growth. To directly
test the impact of MDSCs in the HSD tumor model, we
applied an antibody-mediated depletion of MDSCs by using
anti-GR1 antibodies, known to be very efficient in depleting
MDSCs in mice (42). In line with previous studies (43), this
protocol efficiently depleted MDSCs and neutrophils in the
model system as monitored by FACS analysis in blood and
tumors (Supplementary Figure 12). Importantly, by depleting
MDSCs using anti-GR1 antibodies, the inhibitory effect of
HSD on tumor growth was completely abolished (Figure 4D).
Antibody treated HSD fed animals displayed a similar tumor
growth as animals receiving the control diet. These data indicate
that the population of MDSCs are essential players in the HSD
mediated inhibitory effect on tumor growth.
High Salt Blocks Suppressive Function of
Murine and Human MDSCs
The above data clearly pointed toward phenotypic and functional
changes of MDSCs upon HSD and indicated that these changes
in MDSC populations significantly contributed to the inhibitory
effect of high salt on tumor growth. Although the number of
MDSCs in spleen and tumor was not altered upon HSD, it is
possible that HSD alters the function of these cells. To further
test if high salt may directly affect MDSCs, we analyzed the
impact of increased sodium concentrations onMDSC phenotype
and function in vitro (Figure 5). To mimic in vitro the high salt
conditions in the interstitial tissues of animals receiving a HSD
diet (24, 25), we used an established protocol by increasing the
sodium concentration in cell cultures by adding an additional
40mM of NaCl (1, 3, 4, 33, 34). To test the effects of high salt
on MDSC function we isolated MDSCs from spleens and tumors
of LLC tumor-bearing mice and examined these cells in vitro
for their capacity to suppress effector T cells under control or
high salt conditions (+40mM NaCl). It has been shown that
immature myeloid cells can affect tumor growth also in the
absence of T cells (19) and although the in vivo experiments
in RAG2 deficient mice clearly pointed to a T cell independent
mechanism for myeloid cell mediated tumor growth reduction,
we still resorted to the in vitro T cell suppression assay, as
an established method to analyze changes in immunoregulatory
phenotype after salt exposition.
MDSCs were isolated based on the expression
of specific markers as described before (16, 21)
(Supplementary Figures 13A,B). Of note, high salt conditions
blocked MDSC suppressive capacity in vitro almost completely
(Figure 5A; Supplementary Figure 14A). Particularly, the effect
was observed in M-MDSCs isolated from tumors and spleens
indicating that this subset was highly affected by high sodium
conditions in vitro. A similar tendency, although to a lower
extent, was also observed for PMN-MDSCs (data not shown). As
an osmolyte control, we tested the effects of 80mM mannitol in
cultures but did not observe a similar effect, indicating that the
effect was rather specific to Na+ ions and was not simply due to
changes in osmotic pressure (Supplementary Figure 13C). Of
note, a similar effect of functional inactivation was also observed,
when testing the suppressive capacity of MDSCs isolated from
HSD and control fed mice. MDSCs isolated from tumors of
HSD fed mice showed lower suppressive function compared to
MDSCs isolated from tumors of control fed mice, indicating that
the functional changes occur also under high salt conditions in
vivo (Supplementary Figure 14B).
To examine if this effect may also apply to human MDSCs,
we isolated MDSCs from peripheral blood of cancer patients
(Supplementary Table 1). Since in humans the subset of
PMN-MDSCs have been demonstrated to be the subset
with highest suppressive activity and clinical relevance
in cancer patients (16, 28), we isolated MDSCs as HLA-
DR−CD33dimCD66b+Lin−CD14dim cells from five independent
cancer patients (Figure 5B). We then tested MDSC functionality
in suppression assays under control or high salt (+40mM NaCl)
conditions as measured by fluorescent dye dilution of labeled
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FIGURE 4 | High salt diet mediates changes in myeloid cells in tumor-bearing mice. (A) FlowSOM visualization of flow cytometry data in blood. Single live
CD45+CD11b+ cells for each sample (Ctrl and HSD, n = 6/group) were exported and concatenated then analyzed using FlowSOM, which arranges the cells into
(Continued)
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FIGURE 4 | clusters (represented by circles) according to similarities in their expression profiles. Each node represents one cluster (total = 100 nodes). Colored nodes
highlight statistically significant changes (p < 0.05) in cell population between two groups (HSD and Ctrl). (B) Blood samples from B16 tumor-bearing mice were
analyzed for MDSC populations at day 9 and 14 p.i. FACS plots show representative distribution of M-MDSC-like cells (Ly6-ChighLyG− and PMN-MDSC-like cells
(Ly6CmedLy6-Ghigh) after gating on CD11b+ cells. Bar graphs show the frequency of each population in high salt diet fed mice (HSD) compared to control mice (Ctrl)
as mean ± S.E.M. from 6 mice in each group. Statistical significance was determined by unpaired t-test. (C) Single cell suspensions from spleens and tumors were
analyzed as in (B) at day 16. Dotplots show the frequency of each population in high salt diet fed mice (HSD) compared to control mice (Ctrl) as mean ± S.E.M. from 5
to 6 mice in each group. (D) High salt diet (HSD) fed mice were treated with an anti-GR-1 antibody or PBS as control from day 4 after B16 melanoma cell inoculation
on consecutively every second day. Growth curve shows tumor volume as mean ± S.E.M. of 5 mice in each group. Statistical analysis was performed by Two-way
repeated-measure Anova (**p < 0.01).
T cells as described before (28) (Figure 5C). Of note, high salt
conditions blocked the suppressive function of MDSCs in T cell
suppression assays of all five patients (Figure 5D). This data
clearly show that increased sodium concentrations, mimicking
high salt conditions in tissues of HSD fed animals, could indeed
markedly change the inflammatory phenotype of MDSCs and
alter their function (here shown for immunosuppression) in
mice and humans. While it remains to be shown how exactly
myeloid cells reduce tumor growth, the animal experiments
using HSD show that such changes can directly affect tumor
growth in vivo.
DISCUSSION
High dietary salt intake is believed to be associated with
various diseases (5). Besides implications in cardiovascular
pathologies, recent data have clearly shown that high salt
intake could profoundly modulate the immune system through
direct and indirect mechanisms-mainly leading to shifts toward
a pro-inflammatory milieu (6, 7). However, the majority of
current in vivo data is based on studies in rodents, using
protocols of extremes of high salt intake that likely cannot
extrapolate to humans and therefore findings have to be analyzed
carefully if they can apply to the human situation (7, 44).
Nevertheless, few available studies in humans indicate that even
moderate changes in salt intake could impact host immunity
and clinical parameters in a similar manner compared to
experimental animal studies. For instance, a daily increase
of 6 g NaCl for 14 days seemed to affect already TH17 cell
frequency and blood pressure as reported for a small human
pilot study (4, 45). The data presented here indicates that
a high salt diet could also strongly affect tumor growth
by enhancing anti-tumor immunity through the modulation
of MDSC function. Thus, in the context of an immune
response to cancer, a high salt diet may positively affect
anti-tumor immunity, similar to enhanced immune responses
toward certain pathogens as shown before for Leishmania
infection in skin (2).
In humans, high sodium intake might be a risk factor for the
development of gastric cancer (46, 47). However, animal studies
on gastric cancer development show contradictory results (48–
51) indicating that the exact role of sodium intake in cancer
development is still not well-defined and the stomach represents
a very peculiar milieu because of the acidic nature and the ionic
composition in the gastric mucosa.
When analyzing major immune parameters in tumor-bearing
mice between control and high salt fed mice, we could detect
increases in Tnfa, Ifng, and Nos2 expression in spleen and
tumor tissues, indicating a more pro-inflammatory environment
in HSD mice. Although we couldn’t measure any significant
changes in T cell frequencies between the two groups, HSD
impacted adaptive immune cells in our model, as measured by
increased effector-memory and TH1-like cells in tumor-bearing
mice. However, this was only evident in mLN of tumor-bearing
mice, indicating that these changes may not play a relevant
role for the observed effects. A possible explanation for this
observation might be the known impact of HSD on the gut
microbiota and T cells (4). We neither did detect changes in
TH17 cells, a T cell subpopulation usually enhanced under high
salt conditions particularly in experimental settings of neuro-
and gut-inflammation. However, this can be due to the nature
of the inflammatory conditions of the tumor models used or
due to different time points and tissues analyzed compared to
other experimental models of inflammation under HSD (45). In
contrast to CD4+ T effector cells, we were not able to detect
any significant differences in the CD8+ T cell compartment at
the examined time points in different tissues. Since regulatory
T cells can also critically be affected by high salt (34) and they
greatly impact anti-tumor immunity (52), we also examined
this suppressive CD4+ T cell subset thoroughly in our model.
However, Foxp3+ Tregs didn’t show any differences in frequency
or altered subpopulations [e.g., IFNγ+ TH1-like Tregs (34)]
between both groups in all tissues analyzed. Nevertheless, we
cannot exclude functional changes, since we did not test the
in vitro suppressive capacity of isolated Tregs from tumor-
bearing mice that was shown to be impaired under high salt
conditions in vitro and in humanizedmouse models in settings of
a xenogeneic graft-vs.-host disease model (x-GvHD) in vivo (34).
However, importantly, since we observed almost similar effects
of delayed tumor growth under HSD in RAG2−/− animals, the
effect seems not to be critically dependent on T cells in both
tumor models tested, suggesting that the changes in phenotype
seen in the T cell compartment are a reflection of the changes in
the pro-inflammatory milieu but do not significantly contribute
to tumor control.
Therefore, we further examined innate immune cells in
tumor-bearing mice. Monocyte/macrophages have been shown
before to be sensitive to high salt (2, 3, 37) and particularly
M1-type macrophages were induced to become more pro-
inflammatory in an p38MAPK/NFAT5 dependent manner and
to express higher levels of a pro-inflammatory gene signature,
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FIGURE 5 | High salt conditions block murine and human MDSC function in vitro. (A) MDSCs isolated from LLC tumors and spleens of tumor-bearing mice were
cultured with splenocytes at the indicated ratios in the presence of anti-CD3/CD28 stimulating antibodies. Cells were either cultured under high salt (+40mM NaCl) or
(Continued)
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FIGURE 5 | control conditions (Ctrl). Proliferation of responder splenocytes was measured by 3H-thymidin incorporation. Curves show proliferation normalized to
controls (stimulated splenocytes without addition of MDSCs) as mean ± S.E.M from triplicates representative for three independent experiments with similar results.
(B) PMN-MDSCs were sorted from PBMCs of patients with oropharynx or bladder cancer. FACS plots show the gating strategy. (C) FACS purified human
PMN-MDSC were co-cultured with CPDye405-labeled autologous CD3+ T cells under control (Ctrl) or high salt conditions (+40mM NaCl) for 4 days at a 1:2.5 ratio.
FACS histograms from a representative patient are shown. (D) Graph shows proliferation index from five independent patients under control or high salt (+40mM
NaCl) conditions. Statistical significance was determined by unpaired t-test (*p < 0.05).
including Tnfα and Nos2 (2, 37) two genes that were also highly
induced in HSD fed animals. However, we could not detect
any significant changes in frequencies of monocyte/macrophage
populations locally in the tumor milieu, although we cannot
exclude functional changes on these cells upon HSD. In addition,
we could not detect any changes in NK cell frequencies.
Nevertheless, when analyzing CD11b+Ly6GhighLy6Clow and
CD11b+Ly6G−Ly6Chigh myeloid cell populations in tumor-
bearing animals that include MDSCs, we observed systemically
increased numbers of CD11b+Ly6GhighLy6Clow MDSC-like cells
in high salt fed mice. Particularly in blood at early time points
after tumor inoculation, these PMN-MDSCs seemed to be
increased in cell numbers under HSD compared to controls,
indicating an effect of HSD in tumor-bearing mice in this
myeloid cell population. Since MDSCs are critical modulators
of anti-tumor immunity (16–18) we thus analyzed this subset in
more detail.
Interestingly, the depletion of GR1+ cells annihilated the HSD
effect on tumor growth, clearly pointing toward a functional
role of MDSCs. We thus tested the impact of high sodium
concentrations on the suppressive capacity of MDSCs in vitro,
as a surrogate marker for their suppressive vs. pro-inflammatory
activity. Of note, high salt concentrations in vitro, mimicking
sodium content in tissues of HSD fed animals, significantly
blocked the function of MDSCs isolated from tumor-bearing
mice in suppression assays. Moreover, MDSCs isolated directly
from tumors of HSD fed mice showed similarly a lack of
suppression compared to cells isolated from tumors of control
fed mice. In this respect, it is of interest that a previous study
found accumulation of functional MDSCs in different models
of hypertension, including a salt sensitive setting, implicating
a functional role in blood pressure regulation. However, how
the specific salt sensitive L-NG-Nitroarginine Methyl Ester (L-
NAME) model for hypertension compares to the tumor models
is currently unclear and would be of interest to be investigated in
further studies (53). Our data indicate that high sodium content
may directly affect particularly MDSC function in tumor-bearing
mice, consequently leading to a shift in the immune balance
toward a pro-inflammatory environment. However, since T cells
do not seem to be the major force driving the anti-tumoral effect,
as demonstrated by the RAG2−/− experiments, the key executing
cell type seems to be rather of innate origin. Possibly, as observed
by increases of Tnfa, Ifng, and Nos2 expression, it could well
be that in HSD fed animals besides other innate immune cells
like macrophages, tumor-infiltrating MDSCs themselves became
more pro-inflammatory and anti-tumoral. In this respect it is
of interest that MDSCs were shown to be highly plastic cell
types with the ability to convert toward proinflammatory effector
cells (22).
Importantly, a clear modulation of suppressive activity
under high salt conditions was also observed in circulating
human MDSCs from cancer patients. This indicates that high
salt could similarly affect MDSC function in humans. Thus,
potential molecular changes induced by high salt conditions
may offer novel therapeutic targets to possibly assist cancer
immunotherapy. MDSCs are considered to be a major hurdle
in cancer immunotherapy, preventing efficient immune attack
against tumors e.g., when using checkpoint inhibitors (20,
54). Therefore, the further exploration of this effect may
have potential in immune therapies for targeting MDSC
function. However, the detailed analysis of the molecular
effect has to be addressed in future studies and is out of
the scope of this study. It would be of interest for future
studies to analyze the role of known molecular high salt
targets like p38/MAPK, SGK1 and NFAT5 and if they are
also involved in salt exposed MDSCs, as it has been shown
for T cell and monocyte/macrophage populations. Of note,
p38/MAPK signaling is also of crucial importance for the pro-
inflammatory and pro-tumoral activity of tumor-associated PMN
in humans (55). In addition, it would be of interest to test
in future studies if the functional changes in MDSCs under
high salt exposure are also related to epigenetic remodeling
and changes in immuno-metabolism as observed for M2-type
macrophages (3).
In summary, we show that a high salt diet significantly
delays tumor growth in two independent murine tumor
transplantationmodels. This effect seems to be mediated through
enhanced anti-tumor immunity by a functional inactivation
of MDSCs. Since high salt conditions also affected human
MDSCs in a similar manner, our data suggest that the
targeting of this mechanism could potentially be a novel
beneficial strategy to block MDSC function in settings of
cancer immunotherapy.
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